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Abstract
Background: Co-morbidity is a common phenomenon in the elderly and is considered to be a major threat to quality
of life (QOL). Knowledge of co-existing conditions or patient characteristics that lead to an increased QOL decline is
important for individual care, and for public health purposes. In visually impaired older adults, it remains unclear which
co-existing conditions or other characteristics influence their health-related QOL. Our aim was to present a risk profile
of characteristics and conditions which predict deterioration of QOL in visually impaired older patients.
Methods: Analyses were performed on data from an observational study among 296 visually impaired older patients
from four Dutch hospitals. QOL was measured with the EuroQol-5D (EQ-5D) at baseline and at five-month follow-up.
Nine co-existing condition categories (musculoskeletal; diabetes; heart; hypertension; chronic obstructive pulmonary
disease (COPD) or asthma; hearing impairment; stroke; cancer; gastrointestinal conditions) and six patient
characteristics (age; gender; visual acuity; social status; independent living; rehabilitation type) were tested in a linear
regression model to determine the risk profile. The model was corrected for baseline EQ-5D scores. In addition, baseline
EQ-5D scores were compared with reference scores from a younger visually impaired population and from elderly in
the general population.
Results: From the 296 patients, 50 (16.9%) were lost to follow-up. Patients who reported diabetes, COPD or asthma,
consequences of stroke, musculoskeletal conditions, cancer, gastrointestinal conditions or higher logMAR Visual Acuity
values, experienced a lower QOL. After five months, visual acuity, musculoskeletal conditions, COPD/asthma and stroke
predicted a decline in QOL (R2 = 0.20). At baseline, the visually impaired older patients more often reported moderate
or severe problems on most EQ-5D dimensions than the two reference groups.
Conclusion: In visually impaired older patients, visual acuity, musculoskeletal conditions, COPD/asthma and stroke
predicted a relatively rapid decline in health-related QOL. With this risk profile, a specific referral by the ophthalmologist
to another sub-specialty may have a beneficial effect on the patient's health-related QOL. A referral by the
ophthalmologist or optometrist to a multidisciplinary rehabilitation service seems appropriate for some patients with co-
morbidity. The current results need to be confirmed in studies using pre-structured questionnaires to assess co-
morbidity.
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The co-occurrence of chronic conditions is a common
phenomenon in the elderly and is considered to be a
major threat to quality of life (QOL). Several studies
report an association between the number of conditions
and QOL, where a higher number of diseases is related to
deterioration of physical functioning [1-4], or social and
psychological functioning [5]. The prevalence rates of sev-
eral conditions, including having several chronic condi-
tions at once, increase with age [6].
The same applies to older adults with a visual impairment
or blindness. Large population-based studies in the more
developed countries indicate a prevalence of visual
impairment and blindness ranging from 0.6–2.1% and
0.1–0.9%, respectively [7]. However, Klaver et al., who
compared data from large prevalence studies in developed
countries, showed that the prevalence of visual impair-
ment and blindness increased rapidly after about 70 years
of age [8]. In their study, the most common causes of vis-
ual impairment and blindness were age-related cataract
and age-related macular degeneration (AMD). Due to
demographic aging, these numbers are expected to
increase and this group of patients will cause an increased
demand for ophthalmic consultations [9]. Moreover,
studies among visually impaired older patients found that
co-morbidity was often reported. For example, Brody et al.
found that 78% of older patients reported to have at least
one other condition in addition to AMD. In our own
patient population of visually-impaired older adults with
a variety of eye conditions, 75% reported to have other
conditions in addition to their eye disease [10]. Langelaan
et al. reported that different chronic conditions have a dif-
ferent impact on health-related QOL [11]. Moreover, the
combination of certain conditions may cause an additive
or synergistic effect on QOL [1,12]. Insight into those
combinations that lead to an increased QOL decline is
important for the individual care of patients, and for pub-
lic health purposes [12]. For older patients with an eye
condition it is not yet known which co-existing conditions
lead to an increased vulnerability in terms of health-
related QOL or a decline in QOL.
In addition to co-existing conditions, it is expected that
other characteristics of visually impaired patients (e.g. vis-
ual acuity and socio-demographics) may also influence
their health-related QOL. Another consideration is that
because ophthalmologists (like other sub-specialties)
have limited time per patient they mainly concentrate on
the eyes and less on the broader aspects of health. Assum-
ing that knowledge of specific factors can further assist
ophthalmologists in the care of their patients, the present
study aims to create a risk profile of patient characteristics
and self-reported co-existing conditions which predict a
relatively rapid deterioration in health-related QOL.
Methods
Design
Secondary analyses were performed on data from a non-
randomized follow-up study, which was initially set-up to
investigate the longitudinal effect in terms of vision-
related QOL of optometric and regional multidisciplinary
rehabilitation services [13-15].
Patients
Consecutive patients were recruited from the ophthalmol-
ogy departments of one university hospital and three gen-
eral hospitals in the Netherlands between July 2000 and
January 2003. The eligibility requirements for inclusion in
the non-randomized study were referral to low-vision
services for the first time by an ophthalmologist, age over
50 years, no previous contact with low-vision rehabilita-
tion services, irreversible vision loss, adequate under-
standing of the Dutch language and adequate cognitive
abilities, which were assessed in communication with the
ophthalmologist. Patients who met the inclusion criteria
were informed about the study and were invited to partic-
ipate. Written consent was obtained from all participants,
which included permission for us to use their self-admin-
istered questionnaire data. The study protocol was
approved by the Medical Ethics Committee of the VU Uni-
versity Medical Center Amsterdam, and was conducted
according to the principles of the Declaration of Helsinki.
Measurements
Health-related QOL
QOL was assessed at baseline and at five-month follow-up
with part of the translated EuroQol instrument. The Euro-
Qol is considered to be a generic measure of health status
[16] and consists of the EuroQol 5-Dimensions (EQ-5D)
and the EuroQol Visual Analogue Scale (EQ-VAS). The
EQ-5D consists of five questions covering the dimensions
'mobility' (walking about, confined to bed), 'self-care'
(washing oneself or getting dressed), 'usual activities'
(work, study, household, family or leisure), 'pain or dis-
comfort' and 'anxiety or depression'. Each dimension has
three levels to describe the severity of problems, namely:
1) no problems, 2) moderate problems, and 3) severe
problems. In a descriptive system, a respondent's health
state is then defined by combining the three levels of
severity on each of the five dimensions, which allows for
a possible 243 (= 35) health states to be defined, e.g.
11111, 12322, 22123, etc. Furthermore, for every individ-
ual a single health state value, or utility, can be calculated.
These health state values are set on a scale ranging from 0
(which corresponds to death) to 1 (which corresponds to
a state of perfect health). Negative values correspond to a
state 'worse than death'. Moreover, valuations of the
health states have been made available for the Dutch gen-
eral public [17]; these health state values are referred to as
the EQ-5Dindex. In the present study we did not use thePage 2 of 9
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come measure in the prediction models because it encom-
passes the separate dimensions of QOL in which we were
particularly interested. We used the official Dutch transla-
tion of the EQ-5D [18] and reported the most common
descriptive health states for our study population. The EQ-
5D has been extensively validated, also for Dutch healthy
individuals [19]. There is extensive documentation http:/
/www.euroqol.org on its construct validity, reliability,
and responsiveness for both general and disease-specific
populations.
Prognostic factors
First, at baseline and at five-month follow-up patients
were asked by means of an open-ended question to report
whether they suffered from any condition other than their
eye disease. Afterwards, the self-reported ailments and
complaints were organized into 13 condition categories
[20]: 1) musculoskeletal disorders (e.g. arthritis, rheu-
matic disease, chronic back problems); 2) diabetes; 3)
heart conditions; 4) hypertension; 5) chronic obstructive
pulmonary disease (COPD) or asthma; 6) hearing impair-
ments; 7) consequences of stroke; 8) cancer; 9) dysfunc-
tion of the thyroid gland;10) gastrointestinal conditions;
11) chronic allergies; 12) chronic skin problems; and 13)
psychological problems. At baseline, only 9 of these 13
self-reported condition categories were entered in the pre-
diction model because 4 of the condition categories were
scarcely reported (i.e. chronic allergies, dysfunction of the
thyroid gland, chronic skin and psychological problems)
[10].
Furthermore, age and gender were taken from the
patients' hospital charts. Distance visual acuity was
assessed for all participants by their ophthalmologist. This
was assessed by projection and with habitual correction
for both eyes separately. To enable meaningful computa-
tions, decimal visual acuity values were transformed to
logMAR values (-log10Visual Acuity), where higher values
represent more vision loss, i.e., lower visual acuity values.
According to the World Health Organization, low vision
is defined as a visual acuity < 0.3 (logMAR ≥ 0.52) and/or
a visual field < 20°, and blindness as a visual acuity < 0.05
(logMAR ≥ 1.30) and/or a visual field < 10°. Living inde-
pendently (versus nursing home resident) and social sta-
tus (married or single) were assessed by self-report.
Rehabilitation type was either the optometric service or
the multidisciplinary service, depending on the place of
recruitment of the patient [15].
Statistical analysis
Non-response, loss to follow-up and patient characteristics
Non-response from eligible patients at baseline, and
between baseline and five-month follow-up, was calcu-
lated. To examine differences between participants who
were still in the study after five months and those lost to
follow-up, independent samples t-tests (EQ-5Dindex,
number of co-existing conditions, age), χ2-tests (type of
co-existing conditions, gender, independent living, social
status, rehabilitation type) and Mann-Whitney tests (log-
MAR visual acuity) were used.
In addition to prevalence, the specific co-existing condi-
tions were further explored by establishing which condi-
tions reported at baseline were lost to follow-up, whether
conditions reported at baseline were still reported at fol-
low-up and, finally, which conditions were newly
reported at follow-up. This information was reported to
gain insight into the course of co-morbidity reports
between baseline and follow-up. However, only baseline
co-morbidity reports were entered into the regression
models to assess the risk profile.
To investigate change in the number of self-reported co-
existing conditions and logMAR visual acuity between
baseline and follow-up, we used paired samples t-tests.
Health-related QOL
Before analyzing the prediction models, we started with
some general analyses on the EQ-5D. To put the EQ-5D
scores from the visually impaired older population into
perspective, we compared baseline data of the visually
impaired older patients (mean age 78 years) who reported
having moderate or severe problems on the EQ-5D
dimensions, with a visually impaired adult population
(mean age 42 years) [11] and with an older group (aged
70–79 years) from the general population [21].
Using an independent samples t-test, we examined the
difference in EQ-5Dindex between patients who reported to
have co-morbidity and those who did not. To investigate
overall change in QOL with the EQ-5Dindex between base-
line and follow-up, we used a paired samples t-test.
Prediction model
To determine which self-reported co-existing conditions
and patient characteristics predicted change in QOL after
five months, linear regression analysis was used. Coeffi-
cients that were not significant (p > 0.05) were eliminated
using a manual backward stepwise procedure. Change
was defined by adjusting for the baseline scores of the EQ-
5Dindex [22]; in this way, regression to the mean was cor-
rected simultaneously. A consequence of regression to the
mean is that, by chance, a change between baseline and
follow-up is related to the initial value [22]. To compen-
sate for missing values, sensitivity analyses for different
assumptions were conducted by repeating the final pre-
diction models. The sensitivity analyses provided similar
results to those of the initial analyses and are therefore not
reported here. To gain more insight into the predictionPage 3 of 9
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the EQ-5Dindex baseline score; these analyses show which
independent variables predict EQ-5Dindex scores after five-
month follow-up. Beforehand, the linear assumption was
assessed in univariate regression models and was consid-
ered satisfactory. In addition, co-linearity between varia-
bles was investigated. Pearson's correlations were highest
between age and living in a nursing home (r = 0.29); all
other correlations were (by far) lower than 0.3. Further-
more, residual and diagnostic analyses were checked for
violation of the assumptions underlying the regression
analyses. The distribution of residuals was considered
normal. Data were analyzed using SPSS 14 for Windows.
Results
Non-response and loss to follow-up
A total of 357 patients were eligible for inclusion in the
study; of these, 61 (17.1%) did not participate [13,15]. Of
the remaining 296 patients who completed the baseline
measurements, 50 (16.9%) were lost to follow-up after
five months, and an additional 6 patients (2%) did not
complete the five-month measurement of the EQ-5D. Of
the 50 non-respondents, 10 patients died (3.4%), 35
(11.8%) were either unable to or no longer wished to par-
ticipate, and 5 patients (1.7%) were either untraceable or
the reason for non-response was unknown. Patients who
were lost to follow-up after five months initially reported
worse baseline EQ-5Dindex scores (mean 0.57; SD 0.29)
than those who continued to participate in the study
(mean 0.69; SD 0.24; p = 0.01). There were no major dif-
ferences between the characteristics of the respondents at
baseline and those of the non-respondents at five-month
follow-up (Table 1). Similarly, there were no significant
differences in the baseline reports of co-existing condi-
tions between respondents and non-respondents at five-
month follow-up (data not shown).
Patient characteristics
Table 1 presents the baseline characteristics of the
patients. Of the visually impaired population, in more
than 50% the primary cause of vision loss was AMD.
Three patients (9.1%) who reported to suffer from the
consequences of stroke (n = 33, Table 2) had suffered a
cerebrovascular accident as the primary diagnosis of
vision loss; 38 patients (52.1%) who reported diabetes (n
= 73) had diabetic retinopathy as the primary cause of
vision loss.
There was no significant change in LogMAR visual acuity
between baseline (mean 0.66; SD 0.38) and follow-up
(0.68; SD 0.40; p = 0.19), or in the mean number of co-
existing conditions (mean 1.34; SD 1.0 versus mean 1.28;
SD 1.0; p = 0.20).
Patients reported a median number of co-existing condi-
tions of 1 (range 0–4), and 25% of the patients reported
not to suffer from any co-existing conditions [10]. Table 2
shows that about 25% of the visually impaired popula-
tion reported to have diabetes, heart conditions or musc-
uloskeletal conditions, and that some patients did not
report the co-existing conditions five months later or were
lost to follow-up. For example, 43.5% no longer reported
their hearing impairment, and 21.7% of patients who
reported a hearing impairment at baseline were lost to fol-
low-up. Moreover, 9 other patients 'newly' reported to
have a hearing impairment at five-month follow-up.
Table 1: Characteristics of the respondents at baseline, compared with those of non-respondents at five-month follow-up
Patient characteristics Respondents (n = 246) Non-respondents (n = 50)
Age in years: mean (SD) 78.0 (8.9) 80.3 (7.8)
Gender: female 62.6% 58.0%
LogMAR visual acuity best eye: median [IQR] 0.55 [0.42;0.77] 0.52 [0.41;0.80]
Social status: living alone 52.4% 62.0%
Independent living: 85.8% 78.0%
Rehabilitation type: optometric service 53.7% 58.0%
Co-morbidity: 75.5% 70.0%
Primary cause of visual impairment*
Age-related macular degeneration 53.1% 50.0%
Diabetic retinopathy 13.2% 14.0%
Glaucoma 5.8% 8.0%
Cataract 5.3% 6.0%
Occluded vein 5.3% 6.0%
Other 17.3% 16.0%
SD = standard deviation; IQR = interquartile range;
*Cause of visual impairment in the eye with the better visual acuity as assessed at baseline during a routine clinical
eye examination by the participant's ophthalmologist.Page 4 of 9
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Table 3 presents the most common descriptive health
states of the visually impaired older patients. The health
state "21221" was reported by almost 12%; this indicates
that these patients had moderate problems with 'mobil-
ity', no problems with 'self-care', moderate problems with
'daily activities' and 'pain or discomfort', and no problems
related to 'anxiety or depression'. Furthermore, 40.4%
reported to have health states other than those presented
in Table 3; of those patients, 73 (24.7%) reported a health
state with at least one '3', representing severe problems on
one or more EQ-5D dimensions.
Figure 1 presents baseline percentages of our visually
impaired patients (mean age 78 years) who reported hav-
ing moderate or severe problems on the EQ-5D dimen-
sions. Those proportions were compared with a visually
impaired adult population (mean age 42 years) [11], and
with a general older population (aged 70–79 years) [21].
About 75% of our visually impaired older patient group
reported moderate or severe problems on the 'usual activ-
ities' (moderate 55.9%; severe 19.3%) and 'mobility'
dimensions (moderate 70.9%; severe 1.0%), followed by
'pain and discomfort' (moderate 48.0%; severe 7.1%),
'anxiety or depression' (moderate 39.2%; severe 5.1%)
and 'self-care' (moderate 25.3%; severe 3.7%). This means
that more of the visually impaired older patients reported
having some or severe problems on all dimensions of the
EQ-5D compared with both reference groups. However,
the proportion of visually impaired older patients report-
ing problems related to 'anxiety or depression' was com-
parable to that reported in the reference group of visually
impaired adults (44.5%). Nevertheless, a relatively larger
group of visually impaired older patients reported having
moderate or severe problems related to 'anxiety or depres-
sion' than older persons in the general population
(11.8%).
Figure 2 shows plots of the EQ-5Dindex scores at baseline
and at five-month follow-up. A paired samples t-test
Table 2: Prevalence of co-existing conditions at baseline and the course of response during five months of follow-up.
Co-existing conditions
(n = 296)
Prevalence at baseline
n (% of 296)
Not reported at follow-up
n (%*)
Lost to follow-up
n (%*)
New report at follow-up
n (% of 246)
Diabetes 73 (24.7) 6 (8.2) 10 (13.7) 3 (1.2)
COPD or asthma 32 (10.8) 9 (28.1) 4 (12.5) 5 (2.0)
Heart 67 (22.7) 13 (19.4) 8 (11.9) 8 (3.3)
Stroke 33 (11.2) 6 (18.2) 5 (15.2) 8 (3.3)
Hearing impairments 23 (7.8) 10 (43.5) 5 (21.7) 9 (3.7)
Musculoskeletal 82 (27.8) 18 (22.0) 15 (18.3) 16 (6.5)
Cancer 13 (4.4) 2 (15.4) 4 (30.8) 3 (1.2)
Hypertension 48 (16.3) 14 (29.2) 11 (22.9) 12 (4.9)
Gastrointestinal 15 (5.1) 4 (26.7) 3 (20.0) 6 (2.4)
*Percentages calculated from the number of co-existing disease at baseline, e.g. 6/73 = 8.2%.
Table 3: Most frequently reported EQ-5D health states by the 
patients at baseline
Health state EQ-5Dindex Patients
MOB SC UA PD AD n %
2 1 2 2 1 0.78 34 11.5%
1 1 1 1 1 1.00 28 9.5%
2 1 2 2 2 0.65 24 8.1%
2 2 2 2 1 0.69 15 5.1%
1 1 2 1 2 0.77 14 4.7%
2 1 2 1 1 0.86 14 4.7%
1 1 2 1 1 0.90 12 4.1%
2 1 1 1 1 0.89 12 4.1%
2 2 2 2 2 0.57 12 4.1%
2 1 1 2 1 0.81 11 3.7%
Other health profiles -- 120 40.4%
MOB (mobility); SC (self-care); UA (usual activities); PD (pain/
discomfort);
AD (anxiety/depression); 1 (no problems); 2 (moderate problems); 3 
(severe problems)
Figure 1
Patients (%) reporting moderate or severe problems 
on EQ-5D-dimensions compared with the two refer-
ence groups. MOB (mobility); SC (self-care); UA (usual 
activities); PD (pain/discomfort); AD (anxiety/depression).
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scores between baseline and follow-up. Furthermore,
patients who reported to have co-morbidity, had signifi-
cantly lower EQ-5Dindex baseline scores (mean 0.63; SD
0.26) than those who reported not to have co-morbidity
(mean 0.76; SD 0.21; p < 0.001).
Risk profile
The results of the regression analyses are presented in
Table 4. It can be seen from the first column (all variables)
that patients who reported diabetes, COPD/asthma, con-
sequences of stroke, musculoskeletal conditions, cancer,
gastrointestinal conditions or higher logMAR Visual Acu-
ity values, experienced a lower QOL after five months
compared to patients who did not report those conditions
or who had lower logMAR values. In addition, it can be
seen from the second column that in patients reporting
COPD/asthma, consequences of stroke, musculoskeletal
conditions or a higher LogMAR Visual Acuity, QOL
declined during follow-up. Patients reporting diabetes,
cancer or gastrointestinal conditions had no significant
decline in QOL during the follow-up period. COPD/
asthma, consequences of stroke, musculoskeletal condi-
tions or a higher LogMAR Visual Acuity remained in the
final prediction model after eliminating non-significant
variables (p > 0.05); this means that those variables pre-
dicted a significant decline in EQ-5Dindex scores. These rel-
evant prognostic variables explained 19.8% of the
variance.
Discussion
Our study aimed to provide a risk profile for visually
impaired older patients related to a change in QOL. First,
when not taking specific risk factors into account, for the
entire group there was no significant change in health-
related QOL between baseline and five-month follow-up,
as measured with the EQ-5Dindex. However, we expected
this result to be an underestimation of the decline in QOL
because patients with worse scores were lost to follow-up.
With the risk profile presented in this study it was possible
to determine patients at risk for a relatively rapid decline
in QOL, in addition to patients who already experienced
a low QOL. Patients who reported at baseline to have dia-
betes, COPD/asthma, consequences of stroke, muscu-
loskeletal conditions, cancer, gastrointestinal conditions
or higher logMAR Visual Acuity values (which means
more vision loss) experienced a lower QOL after five
months compared to patients who did not report those
conditions or who had lower logMAR Visual Acuity val-
ues. Patients reporting those conditions (besides their eye
condition) or patients with more vision loss can be con-
sidered target groups who need more attention. Ophthal-
mologists may consider referral to another sub-specialty if
the patient is currently not under treatment for the condi-
tion(s) that they have reported. A referral by the ophthal-
mologist or optometrist to a multidisciplinary
rehabilitation service seems appropriate for patients with
multiple conditions. In addition to reading aids, these
patients may need occupational therapy, specialized
mobility training, more extensive training for using low-
vision aids or help from a social worker, to adapt to their
visual disability. Furthermore, in visually impaired older
patients we found that having COPD/asthma, conse-
quences of stroke, musculoskeletal conditions or more
vision loss predicted a relatively rapid decline in QOL
between baseline and five-month follow-up. The fact that
patients with diabetes, cancer and gastrointestinal condi-
tions did not show a further decline in QOL might indi-
cate that they were under treatment by a clinician or
general practitioner during the study period.
Our results concur with those of Sprangers et al., who
explored the relative impact of diseases on QOL in a large
group of patients with a wide range of chronic conditions
[23]. They reported that patients with gastrointestinal, cer-
ebrovascular and musculoskeletal conditions experienced
the most detrimental impact, those with visual impair-
ments and chronic respiratory conditions experienced an
intermediate impact and, for example, hearing impair-
ments or dermatological conditions appeared to result in
a relatively favorable impact [23].
The results of our study showed that visually impaired
older patients frequently suffer from one or more co-exist-
ing conditions (other than their eye condition), and that
these patients experienced a lower health-related QOL
than patients without any self-reported conditions at
baseline. However, it has been reported that clinicians
EQ-5Dindex scores at baseline compared with those at five-month follow-upFigure 2
EQ-5Dindex scores at baseline compared with those at 
five-month follow-up. Solid line is the identity line; dots on 
the X-axis (at -0.4) represent baseline EQ-5Dindex scores of 
the patients lost to follow-up.
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QOL [24]. Therefore, it might be helpful for ophthalmol-
ogists to understand that low vision and those specific co-
existing conditions cause a measurable extra burden or
even a rapid decline in QOL in older patients. These older
patients already experience a worse QOL than, for exam-
ple, younger visually impaired patients; this was shown by
comparison with reference populations among visually
impaired adults [11], and older adults in the general
Dutch population [21]. In contrast, the fact that our visu-
ally impaired older patients were referred to rehabilitation
services by their ophthalmologist (e.g. to an optometrist
or to a multidisciplinary service) demonstrates that the
ophthalmologist was at least aware of the disabling prob-
lems caused by the low vision of their patients. Although
a referral did not necessarily increase the patient's health-
related QOL (which is not expected from low-vision reha-
bilitation services), an improvement was observed in
some of the vision-related QOL domains. In a previous
non-randomized study among the same group of visually
impaired older patients, we used a disease-specific ques-
tionnaire to measure the effect of low vision rehabilitation
in terms of vision-related QOL [13]. These latter patients
showed an improvement on the 'reading small print'
dimension after five months, for both rehabilitation types
(optometrist/multidisciplinary service). Patients who
went to the multidisciplinary center also improved on the
'adjustment' to vision loss dimension after five months.
Both dimensions were part of the Low Vision Quality of
Life questionnaire [25]. On this questionnaire, the 'basic
aspects' of vision, vision-related 'mobility' and 'visual
(motor) skills' dimensions did not change significantly
after five months. In general, rehabilitation for patients
with irreversible eye conditions is recommended. For
example, in the case of AMD there is usually no medical
treatment available so that rehabilitation is the only
option to adjust to living with a visual disability.
Our study has some limitations. Co-morbidity was assessed
with an open-ended question, and this questioning method
can result in under-reporting compared to more specific
methods [26]. Open-ended questions are considered sub-
optimal for assessing the prevalence of co-existing condi-
tions, because in that case mainly the serious conditions are
reported [27]. In our study it is feasible that the visually
impaired older patients reported those conditions that had
the most impact on their QOL at the time of the measure-
ments. Moreover, when we investigated the reliability of the
self-reported conditions we observed that between baseline
and follow-up the reports on co-morbidity were not stable.
One reason for this was loss to follow-up, and the other was
that the patients did not continue to report the co-existing
conditions which they had reported at baseline. Moreover,
some patients reported co-existing conditions for the first
time at the follow-up measurement. It is not clear whether
these changes in self-reports reflect a true change, or simply a
lack of reports at baseline for which the reasons are not clear.
It is possible that patients were not aware of their condition
at both of the measurement points, either because the symp-
toms were absent or because they had problems with recol-
Table 4: Multivariate regression models for change in QOL between baseline and five-month follow-up
All variables p-value All variables adjusted for
baseline
p-value Relevant variables adjusted
for baseline
p-value
β (SE) β (SE) β (SE)
Baseline EQ5D score -- -- 0.62 (0.06) <0.01 0.65 (0.06) 0.00
Diabetes -0.07 (0.04) 0.05 -0.02 (0.03) 0.49 -- --
COPD or asthma -0.12 (0.05) 0.01 -0.08 (0.04) 0.04 -0.09 (0.04) 0.02
Heart -0.01 (0.04) 0.86 -0.02 (0.03) 0.51 -- --
Stroke -0.16 (0.05) <0.01 -0.10 (0.04) 0.02 -0.10 (0.04) 0.02
Hearing impairment -0.09 (0.06) 0.12 -0.03 (0.05) 0.57 -- --
Musculoskeletal -0.20 (0.04) <0.01 -0.09 (0.03) <0.01 -0.09 (0.03) 0.00
Cancer -0.18 (0.08) 0.03 -0.06 (0.07) 0.37 -- --
Hypertension 0.04 (0.04) 0.35 0.02 (0.04) 0.60 -- --
Gastrointestinal -0.17 (0.07) 0.02 -0.08 (0.06) 0.20 -- --
Age 0.00 (0.002) 0.73 0.00 (0.002) 0.74 -- --
Gender (female) -0.05 (0.03) 0.14 -0.04 (0.03) 0.13 -- --
LogMAR VA -0.14 (0.04) <0.01 -0.09 (0.03) 0.01 -0.07 (0.03) 0.03
Social status (living alone) -0.03 (0.03) 0.35 0.02 (0.03) 0.49 -- --
Independent living 
(nursing home)
-0.07 (0.05) 0.13 -0.03 (0.04) 0.43 -- --
Rehabilitation type 
(optometric service)
0.02 (0.03) 0.58 -0.02 (0.03) 0.49 -- --
β:unstandardized regression coefficient; SE: standard errorPage 7 of 9
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thought that the researchers were already aware of their co-
existing conditions because they had reported them at base-
line; in this case they might have considered it superfluous to
report their (chronic) co-existing condition(s) a second time.
In contrast, Klabunde et al. showed that patients were gener-
ally able to provide reliable reports of their co-existing condi-
tions over time; however, arthritis had the highest
proportion of inconsistent responses [28]. More insight into
the validity of self-reported co-morbidity in open-ended
questions was revealed from our previous study. In that
study, for most condition categories there was a lack of agree-
ment between co-morbidity reports of patients and those of
their GP; the agreement differed per condition, where
patients mostly under-reported. However, for diabetes,
COPD/asthma and heart conditions we found very good to
moderate agreement between the patients and the GPs [10].
The current study did not include a thorough investiga-
tion of the nature of open-ended questions. More research
is needed to establish the reliability of open versus closed-
ended questions administered by patients. Pre-structured
questionnaires are available [29], which should provide a
more complete view of the patient's co-morbidity than
open-ended questions [27]; these are easier to complete
by older patients because they depend less on the recollec-
tion ability of the patients. We do note, however, that
open-ended questions give a more accurate reflection of
how co-morbidity is usually addressed in a clinical setting
[26]. Although we do not have exact information concern-
ing the patient's co-morbidity, in the clinic one is also
confronted with the incompleteness of patient reports.
Nevertheless, we found that self-reported co-morbidity
from open-ended questions predicted a decline in QOL,
with results comparable to those of larger studies [23].
Finally, the EQ-5D is one of the most widely used generic
index measures of health-related QOL [30] and is increas-
ingly used as a stand-alone measure [31]. The question-
naire allowed us to gain insight into various health states,
to compare different sub-groups of our patient population,
and to compare our study population with two reference
groups. However, the EQ-5D has been criticized for having
only three response categories per dimension, which could
lead to lack of measurement precision and responsiveness
(see e.g. Pickard et al.) [32]. For example, on the mobility
dimension it seems to be a large step for patients to choose
between the response categories 2) and 3): where 1) repre-
sents no problems with walking about, 2) moderate prob-
lems with walking about, and 3) being confined to bed.
Therefore, the results of our study on QOL decline may
even be an underestimation of the actual QOL decline in
visually impaired older patients. Furthermore, in the field
of ophthalmology and low vision it is increasingly more
common to use Rasch analysis or other item response the-
ory models to calculate health-related outcome measures,
such as QOL questionnaires [13,33,34]. Some efforts have
been made to use Rasch analyses on the five dimensions to
validate the EQ-5D [32]; however, problems still exist with
these valuations and they have not yet been widely
accepted. For comparability purposes it has been recom-
mended to follow the original validated and widely used
valuations [30].
Conclusion
We believe that the knowledge of specific co-existing con-
ditions is important for public health, the patient's indi-
vidual care and the ophthalmologist whose patients
consist mainly of older adults. Patient's self-reported co-
morbidity and other characteristics may influence the
ophthalmologist's medical decision-making concerning
surgery, or their approach to older patients who often
have complicated drug regimens [35]. Although our
results should be confirmed in an additional study with
pre-structured co-morbidity questionnaires, this study
shows that visually impaired older patients with specific
co-existing conditions and low vision experienced a lower
QOL at follow-up or were at higher risk of a rapid decline
in QOL.
In conclusion, we recommend to actively ask visually
impaired older patients about their musculoskeletal con-
ditions, COPD/asthma and consequences of stroke, and
to continue referring patients with low vision to rehabili-
tation services, according to the guidelines developed in
the USA [36] and in the Netherlands [9]. With a risk pro-
file, as presented in this study, a rehabilitation interven-
tion or a specific referral to another sub-specialty may be
of benefit for the health and vision-related QOL of the
patient and for the involvement of ophthalmologists in
their patient's general health.
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